AOC's Campaign Spent $18,725 on Psychiatrist Tied to Ketamine Therapy
FEC records show AOC's campaign paid a psychiatrist tied to ketamine therapy $18,725 under the label "leadership training and consulting."
Rep. Alexandria Ocasio-Cortez's campaign spent $18,725 in 2025 on payments to Boston psychiatrist Dr. Brian Boyle, according to Federal Election Commission records first highlighted by the New York Post and later reported by Breitbart. The expenses were labeled "leadership training and consulting." That wording is doing a lot of work.
According to the reporting, Boyle is chief psychiatrist at Stella Mental Health, a clinic network that promotes treatments including Spravato, ketamine-assisted therapy, transcranial magnetic stimulation, and stellate ganglion blocks. His Psychology Today profile describes him as specializing in anxiety, depression, trauma, and PTSD, not campaign strategy. Which raises the obvious question: since when did psychiatric treatment become a line item for leadership consulting?
What the campaign records reportedly show
The New York Post reported three payments from AOC's campaign to Boyle in 2025:
$11,550 in March
$2,800 in May
$4,375 in October
Total: $18,725
Those payments were reportedly disclosed to the FEC as "leadership training and consulting." Ocasio-Cortez's campaign did not respond to requests for comment cited in the reporting.
That silence matters. If there is a perfectly ordinary explanation here, this would be a very good time to offer one.
Why critics say this could be a campaign finance problem
Federal campaign law bars candidates from converting donor money to personal use. That does not mean every unusual expense is automatically illegal. It does mean campaigns need a credible political purpose for how donor funds are spent.
Paul Kamenar of the National Legal and Policy Center told the New York Post that the expense appears to violate campaign finance rules against personal use. He also argued that Boyle has no apparent expertise in leadership training comparable to standard political consultants.
That is the key issue.
The story is not really about whether ketamine therapy exists or whether mental health treatment can help people. Of course it can. The question is whether donor money given for campaign activity was used for something that looks a lot more personal than political.
The problem with the label
Calling something "leadership training" does not magically make it campaign work.
If a candidate hires a media consultant, a fundraising adviser, or a debate coach, the campaign purpose is obvious. If a candidate pays a psychiatrist whose own public profiles emphasize ketamine-assisted therapy, depression treatment, PTSD care, and other psychiatric services, donors are entitled to ask what exactly they financed.
And yes, that is an uncomfortable question. Accountability often is.
Boyle's background makes the story harder to brush off
Breitbart and the New York Post both pointed to Boyle's connection to Stella Mental Health. Stella's own website says it offers evidence-based care and advanced psychiatric treatments, including ketamine therapy and Spravato. Boyle's Psychology Today profile likewise presents him as an interventional psychiatrist focused on treatment-resistant conditions and newer psychiatric interventions.
In other words, this is not a consultant who happens to have a medical degree on the side. His public-facing identity is psychiatry.
That matters because the campaign's explanation, at least on paper, was not "mental health treatment." It was "leadership training and consulting."
Those are not the same thing.
What supporters might say
To be fair, there are possible defenses here:
Campaign leadership can be stressful and psychologically demanding
Executive coaching and performance consulting sometimes overlap with mental health expertise
Public reporting does not yet show what the sessions actually involved
Fine. All true.
But if that is the defense, the campaign still needs to explain the political function clearly. Vague labels and no comment are not exactly confidence-builders.
AOC's past interest in psychedelics adds context
This is also not happening in a vacuum. Ocasio-Cortez has previously supported expanded research into psychedelics for mental health treatment. The New York Post noted she pushed multiple times for federal research on substances such as psilocybin, and later backed legislation connected to psychedelic research for service members.
That background does not prove wrongdoing. It does, however, make the campaign spending story more politically relevant. Critics are not just looking at a random vendor payment. They are looking at payments to a psychiatrist tied to novel therapies that align with Ocasio-Cortez's own public interest in alternative mental health treatments.
Because of course they are.
Why grassroots conservatives should care
You do not have to oppose mental health treatment to see the problem here. This is about stewardship and honesty.
When campaigns ask small donors for money, they are not asking for a blank check. They are asking people who can barely afford groceries, gas, and rent to help finance political work. If those funds are being routed into expenses that look personal, specialized, or conveniently mislabeled, voters deserve answers.
Here are the questions that still need answers:
What services did Boyle actually provide to the campaign?
Who participated in those sessions?
Were the services political, medical, or some mix of both?
Why was a psychiatrist the chosen provider for "leadership training"?
What documentation supports the campaign's classification of the spending?
Those are basic oversight questions. Not partisan hysteria. Basic oversight.
The bottom line
AOC's campaign reportedly spent $18,725 in donor money on a psychiatrist whose public profile centers on ketamine-assisted therapy and related psychiatric treatments. The campaign labeled the expense "leadership training and consulting" and, according to the reporting, offered no public explanation.
Maybe there is one. Maybe there is not.
But when donor cash and therapeutic services start sharing the same disclosure line, people are going to notice. They should. If Democrats want to lecture the country about ethics, transparency, and public trust, they might start by explaining why a psychiatrist tied to ketamine therapy ended up on a campaign payroll under what looks like the vaguest label money can buy.
That is not a right-wing conspiracy. That is what the filing says.